GlaxoSmithKline - Top 10 Layoffs of 2010

Company: GlaxoSmithKline
Layoffs: 5,201

Scoop: CEO Andrew Witty spent the year finding cost-saving options for the company, including laying off workers in Europe and the U.S., including 700 from the sales and marketing division. GSK believes the future is in emerging markets, particularly in Asia and South America, and its transferring much of its muster into those areas with numerous deals.

But beyond layoffs, Witty looked at other failing strategies, including spending £3 billion in nine years on research that found no new products.

GlaxoSmithKline - Top 10 Layoffs of 2010
Read more on

Suggested Articles

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.

Rather than "we did the best we could," Vas Narasimhan, during an internal call with managers, said Novartis could have handled the Zolgensma crisis…

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.